by Adrian Beer | Nov 25, 2025 | Commercialisation, Innovation Policy
Diversified institutional risk verse concentrated company risk Australia’s innovation debate circles endlessly around institutional coordination, ecosystem integration and patient capital. These conversations identify real challenges but systematically avoid a...
by theotherdimension | Sep 18, 2025 | Commercialisation, Innovation Policy
The UK tried academic leadership for commercialisation. Here’s why it failed. Before Australia rushes to create more research institutes, we should examine what happened when the UK tried this approach. Britain’s £2.5 billion Catapult investment provides a...
